The Global Transplant Diagnostics Market Size is valued at 4.29 billion in 2022 and is predicted to reach 8.26 billion by the year 2031 at a 7.72% CAGR during the forecast period for 2023-2031.
The rise in organ transplants is a significant aspect driving demand for diagnostics utilized before surgery. There has always been a greater need for transplants than available organs. Nonetheless, the market will likely profit from in-depth field study and analysis to close this gap. The European Commission's initiatives for organ harvesting have made donated organs available. The availability of the European donor card and rising public awareness have further increased the region's organ donation rate. Similar to other countries, the U.S. has seen significant organ donation increases due to increased awareness.
Also, the demand for organ transplant surgeries is increasing due to the rising number of patients with chronic illnesses that frequently cause organ failure. Personalized medicine and stem cell therapy are also becoming more widely used. Pre-procedure diagnostics are in high demand as a result. Improved and sophisticated diagnostic methods are required due to the risks and complexity of organ transplantation.
Recent Developments:
- In March 2022, Immucor, Inc., a business specialising in transfusion and transplantation diagnostics, introduced two new products to its transplant diagnostics line, proving its dedication to recent developments in the histocompatibility industry.
Competitive Landscape:
Some of the primary Transplant Diagnostics market players are:
- Abbott Laboratories, Inc.
- Adaptive Biotechnologies
- Affymetrix, Inc.
- altona Diagnostics GmbH
- Arquer Diagnostics Ltd
- BAG Diagnostics GmbH
- Becton, Dickinson and Company,
- Biofortuna Limited
- BioMerieux SA,
- Bio-rad Laboratories, Inc.
- Biotype GmbH
- Bruker,
- CareDx Inc.
- CLONIT srl
- Diagnóstica Longwood SL
- DiaSorin S.p.A.
- ELITechGroup
- EUROFINS VIRACOR
- Hoffmann La-Roche AG.
- Hologic, Inc.
- Horiba Ltd
- Illumina, Inc.
- Immucor Transplant Diagnostics, Inc.
- Laboratory Corporation of America Holdings.
- Linkage Biosciences
- Luminex Corporation
- Merck KGaA
- NanoString
- Olerup SSP AB
- Omixon Ltd.
- PathoNostics
- Preservation Solutions, Inc.
- Qiagen N.V.
- Randox Laboratories Ltd.
- Stryker
- Takara Bio Inc.
- Thermo Fisher Scientific,
- TransMedics
- Transonic
- Zimmer Biomet
Market Segmentation:
The Transplant Diagnostics market is segmented on the basis of product & service, application, technology, transplant type, and end-user. Based on technology, the market is segmented into molecular assay technologies, sequencing-based molecular assays, and nonmolecular assay technologies. The product & service segment includes consumables, instruments, and software & services. By application, the market is segmented into diagnostic applications and research applications. By transplant type, the market is segmented as solid organ, stem cell, soft tissue, and bone marrow transplantation. End-use segment includes hospitals & Transplant services, research & academic institutes, and independent reference laboratories.
Based On Product & Services, The Software & Services Segment Is Accounted As A Major Contributor In The Transplant Diagnostics Market.
Reagents and consumables are anticipated to expand first, followed by the services and software category. The introduction of more complex instruments has raised the need for training sessions to instruct technical employees on handling and usage, which has contributed to the expansion of this market. Also, the industry growth is being fueled by elements like regular software upgrades and better services provided by market competitors to remain competitive.
Pre-Transplantation Diagnostics Segment Witnessed Growth At A Rapid Rate.
The producers of these diagnostic products are using tactics like purchasing agreements for reagents and consumables. Moreover, the frequent procurement of reagents and consumables is a crucial element in speeding adoption. As a result, the category had the highest revenue share in 2016 and is anticipated to continue to hold the top spot throughout the projected period.
In The Region, The North America Transplant Diagnostics Market Holds A Significant Revenue Share.
The majority of revenue came from North America. Key influences include the widespread use of cutting-edge methods and diagnostic technologies, rising healthcare costs, and the accessibility of qualified personnel. Due to factors including a highly established healthcare infrastructure and the availability of qualified specialists, the U.S. has the most significant market share. Also, the widespread use of stem cell therapies, tailored pharmaceuticals, and soft tissue transplants is promoting regional market expansion.
Transplant Diagnostics Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 4.29 Bn |
|
Revenue forecast in 2031 |
USD 8.26 Bn |
|
Growth rate CAGR |
CAGR of 7.7 % from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Product & Service, Application, Technology, Transplant Type, And End-User. |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
BioMerieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Bio-Rad Laboratories, Bruker, and Merck KGaA. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
